CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
Authors
Alfredo Damasceno
Andre Palma da Cunha Matta
+19 more
Baumgartner A
Capobianco M
Derfuss T
Eber Castro Correa
Ernane Pires Maciel
Fragoso YD
Iaffaldano P
Jefferson Becker
Joseph Bruno Bidin Brooks
Kappos L
Kurtzke JF
Paulo Diniz da Gama
Rispens T
Rodrigo Assad da Gama
Soniza Vieira Alves-Leon
Stüve O
Thereza Cristina d’Avila Winckler
Tur C
Yara Dadalti Fragoso
Publication date
Publisher
'FapUNIFESP (SciELO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1590%2F0004-282x20...
Last time updated on 01/04/2019